Marianne Santaguida
Affiliations: | 2009 | University of California, San Francisco, San Francisco, CA |
Google:
"Marianne Santaguida"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Stieglitz E, Gu CJ, Richardson M, et al. (2023) Tretinoin Enhances the Effects of Chemotherapy in Juvenile Myelomonocytic Leukemia Using an Ex Vivo Drug Sensitivity Assay. Jco Precision Oncology. 7: e2300302 |
| Branstrom A, Cao L, Furia B, et al. (2022) Emvododstat, a Potent Dihydroorotate Dehydrogenase Inhibitor, Is Effective in Preclinical Models of Acute Myeloid Leukemia. Frontiers in Oncology. 12: 832816 |
| Aleshin A, Greenberg PL, Medeiros BC, et al. (2018) Abstract 3004: Single-cell mutational profiling of clonal evolution in myelodysplastic syndromes (MDS) during therapy and disease progression Cancer Research. 78: 3004-3004 |
| Damelin M, Bankovich A, Park A, et al. (2015) Anti-EFNA4 Calicheamicin Conjugates Effectively Target Triple-Negative Breast and Ovarian Tumor-Initiating Cells to Result in Sustained Tumor Regressions. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Damelin M, Bankovich A, Park A, et al. (2015) Abstract 5425: An anti-Ephrin-A4 calicheamicin conjugate effectively targets triple-negative breast and ovarian tumor-initiating cells to result in sustained tumor regression Cancer Research. 75: 5425-5425 |
| Sansregret L, Gallo D, Santaguida M, et al. (2010) Hyperphosphorylation by cyclin B/CDK1 in mitosis resets CUX1 DNA binding clock at each cell cycle. The Journal of Biological Chemistry. 285: 32834-43 |
| Santaguida M, Schepers K, King B, et al. (2009) JunB protects against myeloid malignancies by limiting hematopoietic stem cell proliferation and differentiation without affecting self-renewal. Cancer Cell. 15: 341-52 |
| Sabnis AJ, Cheung LS, Dail M, et al. (2009) Oncogenic Kras initiates leukemia in hematopoietic stem cells. Plos Biology. 7: e59 |
| Santaguida MT, Schepers K, King BC, et al. (2008) JunB Limits Hematopoietic Stem Cell (HSC) Functions as a Protective Mechanism against Initiation of Myeloid Malignancy Blood. 112: 1358-1358 |
| Santaguida M, Schepers K, King B, et al. (2007) Deciphering JunB Function in Regulating Hematopoietic Stem Cell Functions. Blood. 110: 777-777 |